NRx Pharmaceuticals' (NRXP) Hope Therapeutics unit said Monday it signed a letter of intent to acquire a majority stake in Neurospa TMS Holdings in a cash and equity deal.
Financial terms were not disclosed.
Neurospa runs six interventional psychiatry clinics in Florida, Hope said, adding that the takeover will be accretive to its 2025 revenue estimates.
NRx's stock rose 4.3% in recent Monday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.